We are live on ! Find out more
CRBU icon

Caribou Biosciences
CRBU

104 hedge funds and large institutions have $313M invested in Caribou Biosciences in 2022 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 43 increasing their positions, 18 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

139% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 18

109% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 11

88% more call options, than puts

Call options by funds: $352K | Put options by funds: $187K

12% more funds holding

Funds holding: 93 → 104 (+11)

4.61% more ownership

Funds ownership: 51.61% → 56.22% (+4.6%)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

33% less capital invested

Capital invested by funds: $465M → $313M (-$151M)

Holders
104
Holders Change
+11
Holders Change %
+11.83%
% of All Funds
1.64%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
23
Increased
43
Reduced
18
Closed
11
Calls
$352K
Puts
$187K
Net Calls
+$165K
Net Calls Change
+$76K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$16.4M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$11.5M
3
PAMS
Pictet Asset Management (Switzerland)
Switzerland
+$8.09M
4
JP Morgan Chase
JP Morgan Chase
New York
+$5.24M
5
State Street
State Street
Massachusetts
+$3.48M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$13.8M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$10.9M
3
Coatue Management
Coatue Management
New York
-$8.41M
4
CCM
CloudAlpha Capital Management
Hong Kong
-$6.26M
5
FCM
Farallon Capital Management
California
-$3.23M
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
$2.37M +$8.07K +766 +0.3%
D.E. Shaw & Co
27
D.E. Shaw & Co
New York
$2.09M +$913K +86,666 +61%
Charles Schwab
28
Charles Schwab
California
$1.97M +$759K +72,029 +51%
VCIM
29
Velan Capital Investment Management
Georgia
$1.93M – – –
Morgan Stanley
30
Morgan Stanley
New York
$1.86M +$1.05M +99,820 +97%
N
31
Nuveen
North Carolina
$1.76M +$1.36M +129,399 +206%
SCM
32
Shelton Capital Management
Colorado
$1.67M – – –
ROTUOC
33
Regents of the University of California
California
$1.66M +$1.91M +181,304 New
Mirae Asset Global Investments
34
Mirae Asset Global Investments
South Korea
$1.39M -$292K -27,748 -16%
Renaissance Technologies
35
Renaissance Technologies
New York
$1.33M +$518K +49,151 +51%
Bank of New York Mellon
36
Bank of New York Mellon
New York
$1.3M +$774K +73,427 +108%
Janus Henderson Group
37
Janus Henderson Group
United Kingdom
$1.25M -$10.9M -1,035,923 -88%
CSS
38
Cubist Systematic Strategies
Connecticut
$987K +$1.12M +106,419 +9,674%
AG
39
Artal Group
Luxembourg
$967K -$3.16M -300,000 -74%
LCM
40
Laurion Capital Management
New York
$933K -$141K -13,400 -12%
SAM
41
Stansberry Asset Management
Texas
$852K +$268K +25,418 +38%
EC
42
EcoR1 Capital
California
$689K – – –
VIA
43
Vident Investment Advisory
Georgia
$664K +$127K +12,060 +20%
Ensign Peak Advisors
44
Ensign Peak Advisors
Utah
$648K +$61.3K +5,820 +9%
WP
45
Woodline Partners
California
$632K – – –
NCM
46
Nelson Capital Management
California
$595K +$683K +64,858 New
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
$589K +$450K +42,690 +199%
Swiss National Bank
48
Swiss National Bank
Switzerland
$523K +$44.3K +4,200 +8%
Qube Research & Technologies (QRT)
49
Qube Research & Technologies (QRT)
United Kingdom
$461K +$530K +50,258 New
GAA
50
Green Alpha Advisors
Colorado
$456K +$148K +14,082 +40%
1
2
3 4 5

CRBU Hedge Fund Activity: Q1 2022 in Review

104 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Caribou Biosciences (CRBU) for Q1 2022, worth a combined $313M — down 33% from $465M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new CRBU positions and 11 closed out — a net gain of 12 holders — while 43 added to existing stakes and 18 trimmed.

The largest buyer was BlackRock, adding an estimated $16.4M. The largest seller was Fidelity Investments, cutting an estimated $13.8M.

  • 104 institutional investors held Caribou Biosciences (CRBU) as of Q1 2022, up from 93 in Q4 2021.
  • Funds reported $313M of Caribou Biosciences stock for Q1 2022, down 33% quarter-over-quarter.
  • 23 funds opened new Caribou Biosciences positions in Q1 2022 and 11 closed out, a net change of +12 holders.
  • The largest Caribou Biosciences buyer in Q1 2022 was BlackRock, an estimated $16.4M added.
  • The largest Caribou Biosciences seller in Q1 2022 was Fidelity Investments, an estimated $13.8M sold.

Based on aggregated 13F filings for Q1 2022.